A Phase II Study of Brentuximab Vedotin Plus Adriamycin and Dacarbazine without Radiation in Non-Bulky Limited Stage Classical Hodgkin Lymphoma
暂无分享,去创建一个
A. LaCasce | D. Neuberg | P. Armand | E. Jacobsen | B. Shah | J. Abramson | L. Sokol | C. Bello | F. Lansigan | J. Barnes | R. Redd | E. Bengtson | R. Takvorian